RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine

Influenza vaccine effectiveness could be improved by combination with an adjuvant with the potential to enhance the host-vaccine response both quantitatively and qualitatively. The goal of this study was to explore a RIG-I agonist (SDI-nanogel) and a TLR7/8 agonist (Imidazoquinoline (IMDQ)‐PEG‐Chol)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jangra, Sonia, Laghlali, Gabriel, Choi, Angela, Rathnasinghe, Raveen, Chen, Yong, Yildiz, Soner, Coughlan, Lynda, García-Sastre, Adolfo, De Geest, Bruno G., Schotsaert, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679288/
https://www.ncbi.nlm.nih.gov/pubmed/36426358
http://dx.doi.org/10.3389/fimmu.2022.974016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679288/
https://www.ncbi.nlm.nih.gov/pubmed/36426358
http://dx.doi.org/10.3389/fimmu.2022.974016

Ejemplares similares